FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094080303> ?p ?o ?g. }

• W3094080303 abstract "Abstract Background Acute pulmonary embolism (PE) is one of the most critical cardiovascular diseases. PE treatment ranges from anticoagulation, and systemic thrombolysis to surgical embolectomy and catheter embolectomy. Surgical pulmonary embolectmy (SPE) indications and outcomes are still controversial. Although there have been more favourable SPE reports over the past decades, SPE has not yet been considered broadly as an initial PE therapy and is still considered as a reserve or rescue treatment for acute massive PE when systemic thrombolysis fails. This study aimed to evaluate the early and midterm outcomes of SPE, which was a first-line therapy for acute central major PE in one Chinese single centre. Methods A retrospective review of patients who underwent SPE for acute PE was conducted.Patients with chronic thrombus or who underwent thromboendarterectomy were excluded. SPE risk factors for morbidity and mortality were reviewed, and echocardiographic examination were conducted for follow-up studies to access right ventricular function. Results Overall, 41 patients were included; 17 (41.5%) had submassive PE, and 24 (58.5%) had massive PE. Mean cardiopulmonary bypass time was 103.2 ± 48.9 min, and 10 patients (24.4%) underwent procedures without aortic cross-clamping. Ventilatory support time was 78 h (range, 40–336 h), intensive care unit stay was 7 days (range, 3–13 days), and hospital stay was 16 days (range, 12–23 days). Operative mortalities occurred in 3 massive PE patients, and no mortality occurred in submassive PE patients. The overall SPE mortality rate was 7.31% (3/41). If two systemic thrombolysis cases were excluded, SPE mortality was low (2.56%,1/39), evenlthough there were 2 cases of cardiac arrest preoperatively. Patients’ right ventricle function improved postoperatively in follow-ups.There were no deaths related to recurrent PE and chronic pulmonary hypertension in follow-ups, though 3 patients died of cerebral intracranial bleeding, gastric cancer,and brain cancer at 1 year, 3 years, and 8 years postoperatively, respectively. Conclusions SPE presented with a low mortality rate when rendered as a first-line treatment in selected massive and submassive acute PE patients. Favorable outcomes of right ventricle function were also observed in the follow-ups. SPE should play the same role as ST in algorithmic acute PE treatment." @default.
• W3094080303 created "2020-10-29" @default.
• W3094080303 creator A5001211507 @default.
• W3094080303 creator A5010645216 @default.
• W3094080303 creator A5017546410 @default.
• W3094080303 creator A5048651841 @default.
• W3094080303 creator A5053930806 @default.
• W3094080303 creator A5058761585 @default.
• W3094080303 creator A5058889686 @default.
• W3094080303 creator A5063491849 @default.
• W3094080303 creator A5077572891 @default.
• W3094080303 date "2020-10-21" @default.
• W3094080303 modified "2023-10-14" @default.
• W3094080303 title "Clinical outcomes of acute pulmonary embolectomy as the first-line treatment for massive and submassive pulmonary embolism: a single-centre study in China" @default.
• W3094080303 cites W1830697989 @default.
• W3094080303 cites W1919065085 @default.
• W3094080303 cites W1990888709 @default.
• W3094080303 cites W2016717852 @default.
• W3094080303 cites W2069707425 @default.
• W3094080303 cites W2090304485 @default.
• W3094080303 cites W2092592897 @default.
• W3094080303 cites W2095525872 @default.
• W3094080303 cites W2115055475 @default.
• W3094080303 cites W2271112947 @default.
• W3094080303 cites W2357827461 @default.
• W3094080303 cites W2462759741 @default.
• W3094080303 cites W2583773865 @default.
• W3094080303 cites W2598170899 @default.
• W3094080303 cites W2621600407 @default.
• W3094080303 cites W2781429625 @default.
• W3094080303 cites W2888018079 @default.
• W3094080303 cites W2942209039 @default.
• W3094080303 cites W2950684561 @default.
• W3094080303 cites W2970101385 @default.
• W3094080303 cites W4296148784 @default.
• W3094080303 doi "https://doi.org/10.1186/s13019-020-01364-z" @default.
• W3094080303 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7576708" @default.
• W3094080303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33087152" @default.
• W3094080303 hasPublicationYear "2020" @default.
• W3094080303 type Work @default.
• W3094080303 sameAs 3094080303 @default.
• W3094080303 citedByCount "10" @default.
• W3094080303 countsByYear W30940803032022 @default.
• W3094080303 countsByYear W30940803032023 @default.
• W3094080303 crossrefType "journal-article" @default.
• W3094080303 hasAuthorship W3094080303A5001211507 @default.
• W3094080303 hasAuthorship W3094080303A5010645216 @default.
• W3094080303 hasAuthorship W3094080303A5017546410 @default.
• W3094080303 hasAuthorship W3094080303A5048651841 @default.
• W3094080303 hasAuthorship W3094080303A5053930806 @default.
• W3094080303 hasAuthorship W3094080303A5058761585 @default.
• W3094080303 hasAuthorship W3094080303A5058889686 @default.
• W3094080303 hasAuthorship W3094080303A5063491849 @default.
• W3094080303 hasAuthorship W3094080303A5077572891 @default.
• W3094080303 hasBestOaLocation W30940803031 @default.
• W3094080303 hasConcept C126322002 @default.
• W3094080303 hasConcept C141071460 @default.
• W3094080303 hasConcept C160022790 @default.
• W3094080303 hasConcept C164705383 @default.
• W3094080303 hasConcept C167135981 @default.
• W3094080303 hasConcept C179755657 @default.
• W3094080303 hasConcept C2776265017 @default.
• W3094080303 hasConcept C2776376669 @default.
• W3094080303 hasConcept C2776652129 @default.
• W3094080303 hasConcept C2778789114 @default.
• W3094080303 hasConcept C2779581417 @default.
• W3094080303 hasConcept C2781362458 @default.
• W3094080303 hasConcept C500558357 @default.
• W3094080303 hasConcept C71924100 @default.
• W3094080303 hasConceptScore W3094080303C126322002 @default.
• W3094080303 hasConceptScore W3094080303C141071460 @default.
• W3094080303 hasConceptScore W3094080303C160022790 @default.
• W3094080303 hasConceptScore W3094080303C164705383 @default.
• W3094080303 hasConceptScore W3094080303C167135981 @default.
• W3094080303 hasConceptScore W3094080303C179755657 @default.
• W3094080303 hasConceptScore W3094080303C2776265017 @default.
• W3094080303 hasConceptScore W3094080303C2776376669 @default.
• W3094080303 hasConceptScore W3094080303C2776652129 @default.
• W3094080303 hasConceptScore W3094080303C2778789114 @default.
• W3094080303 hasConceptScore W3094080303C2779581417 @default.
• W3094080303 hasConceptScore W3094080303C2781362458 @default.
• W3094080303 hasConceptScore W3094080303C500558357 @default.
• W3094080303 hasConceptScore W3094080303C71924100 @default.
• W3094080303 hasFunder F4320321878 @default.
• W3094080303 hasIssue "1" @default.
• W3094080303 hasLocation W30940803031 @default.
• W3094080303 hasLocation W30940803032 @default.
• W3094080303 hasLocation W30940803033 @default.
• W3094080303 hasLocation W30940803034 @default.
• W3094080303 hasLocation W30940803035 @default.
• W3094080303 hasOpenAccess W3094080303 @default.
• W3094080303 hasPrimaryLocation W30940803031 @default.
• W3094080303 hasRelatedWork W1969673488 @default.
• W3094080303 hasRelatedWork W2031079304 @default.
• W3094080303 hasRelatedWork W2090304485 @default.
• W3094080303 hasRelatedWork W2098733091 @default.
• W3094080303 hasRelatedWork W2172277457 @default.
• W3094080303 hasRelatedWork W2322726978 @default.
• W3094080303 hasRelatedWork W2380402647 @default.
• W3094080303 hasRelatedWork W2419139487 @default.

• next